Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Recombinant Protein Expression in Escherichia Coli (E.Coli): What We Need to Know Publisher Pubmed



Hayat SMG1 ; Farahani N2 ; Golichenari B3 ; Sahebkar A4, 5, 6
Authors

Source: Current Pharmaceutical Design Published:2018


Abstract

Background: Host, vector, and culture conditions (including cultivation media) are considered among the three main elements contributing to a successful production of recombinant proteins. Accordingly, one of the most common hosts to produce recombinant therapeutic proteins is Escherichia coli. Methodology: A comprehensive literature review was performed to identify important factors affecting production of recombinant proteins in Escherichia coli. Results: Escherichia coli is taken into account as the easiest, quickest, and cheapest host with a fully known genome. Thus, numerous modifications have been carried out on Escherichia coli to optimize it as a good candidate for protein expression and; as a result, several engineered strains of Escherichia coli have been designed. In general; host strain, vector, and cultivation parameters are recognized as crucial ones determining success of recombinant protein expression in Escherichia coli. In this review, the role of host, vector, and culture conditions along with current pros and cons of different types of these factors leading to success of recombinant protein expression in Escherichia coli were discussed. Conclusion: Successful protein expression in Escherichia coli necessitates a broad knowledge about physico-chemical properties of recombinant proteins, selection among common strains of Escherichia coli and vectors, as well as factors related to media including time, temperature, and inducer. © 2017 Bentham Science Publishers.
Other Related Docs
8. Glucose Oxidase: Applications, Sources, and Recombinant Production, Biotechnology and Applied Biochemistry (2022)
11. Optimization of the Expression of Reteplase in Escherichia Coli, Research in Pharmaceutical Sciences (2011)
13. Inactivation of Apre Gene in Bacillus Subtilis 168 by Homologus Recombination, Avicenna Journal of Medical Biotechnology (2014)